GREY:NEPTF - Post by User
Post by
gwrbion May 28, 2010 10:15am
298 Views
Post# 17139724
Not much in the results release
Not much in the results release
Results still burdened with the production ramp up from last summer and ongoing R&D costs.
But otherwise, not fussed with the operating loss. Don't know about the cash burn, but don't expect it will be significant.
I like that they finally mention Bayer by name (first time since last June).
2011 must show upward momentum on revenues and margins. Q4 revenues at $4.6M annualizes at close to $20M - that is very promising.
Not sure on the shareholder rights plan. But smells like an executive driven initiative to protect them, in case of a takeover. Could also tie back to the pending new stock issuance - the institutions about to commit new capital may want a say over any takeover talks.
Makes sense. NTB is trading at less than $2. Big pharma comes in and offers $4. Sure double, retail investors take the quick return. Family, management and institutional investors have longer term $10 - $25 value dreams. They want to be able to nix the takeover.
The reality is if there is an unsolicited offer of $4 from a large player, the SP rockets to $4 and the retail investor can sell out. The Board, etc. can still elect to thwart the takeover and carry on.